Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  762 results for ""ECULIZUMAB""

Your Filters

Content Provider : Consumer Health Complete - EBSCOhost
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes.

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; TREATMENT effectivenessNETHERLANDS

  • Source: European Journal of Haematology. Jun2023, Vol. 110 Issue 6, p648-658. 11p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Long‐term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real‐world setting.

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; LACTATE dehydrogenaseESSEN (Germany)

  • Source: European Journal of Haematology. Jul2023, Vol. 111 Issue 1, p84-95. 12p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Starting eculizumab as rescue therapy in refractory myasthenic crisis.

Subjects: MYASTHENIA gravis; ECULIZUMAB; NEUROMUSCULAR diseases

  • Source: Neurological Sciences. Oct2023, Vol. 44 Issue 10, p3707-3709. 3p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Long-term effectiveness of eculizumab: Data from the International PNH Registry.

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; PROPORTIONAL hazards models

  • Source: European Journal of Haematology. Nov2023, Vol. 111 Issue 5, p796-804. 9p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Utilizing therapeutic drug monitoring to optimize therapy with eculizumab and mycophenolate mofetil in a child with C3 glomerulonephritis.

Subjects: THERAPEUTIC use of monoclonal antibodies; HYPERTENSION; ANTIHYPERTENSIVE agents

  • Source: Pediatric Nephrology. Oct2023, Vol. 38 Issue 10, p3483-3487. 5p. 1 Graph.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes.

Subjects: THERAPEUTIC use of monoclonal antibodies; PNEUMONIA; CHRONIC kidney failure

  • Source: Pediatric Nephrology. Dec2023, Vol. 38 Issue 12, p4209-4215. 7p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab.

Subjects: COVID-19; MYASTHENIA gravis; ECULIZUMAB

  • Source: Neurological Sciences. Jul2022, Vol. 43 Issue 7, p4081-4083. 3p. 1 Color Photograph, 1 Chart.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review.

Subjects: THERAPEUTIC use of monoclonal antibodies; ONLINE information services; MEDICAL databases

  • Source: Pediatric Nephrology. Jan2023, Vol. 38 Issue 1, p61-75. 15p. 1 Color Photograph, 1 Diagram, 2 Charts.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eculizumab as a promising rescue therapy for acute exacerbations of myasthenia gravis.

Subjects: MYASTHENIA gravis; DISEASE exacerbation; ECULIZUMAB

  • Source: Neurological Sciences. Dec2023, Vol. 44 Issue 12, p4573-4574. 2p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.

Subjects: HEMOLYTIC-uremic syndrome; ECULIZUMAB; DRUG monitoring

  • Source: British Journal of Clinical Pharmacology. May2024, Vol. 90 Issue 5, p1312-1321. 10p.

Record details

Read More Add to Saved list
×
  • 1-10 of  762 results for ""ECULIZUMAB""